299 related articles for article (PubMed ID: 8957032)
21. Determinants of cardiorenal damage progression in normotensive and never-treated hypertensive subjects.
Fesler P; Ribstein J; du Cailar G; Mimran A
Kidney Int; 2005 May; 67(5):1974-9. PubMed ID: 15840046
[TBL] [Abstract][Full Text] [Related]
22. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure.
Tucker B; Fabbian F; Giles M; Thuraisingham RC; Raine AE; Baker LR
Nephrol Dial Transplant; 1997 Apr; 12(4):724-8. PubMed ID: 9141001
[TBL] [Abstract][Full Text] [Related]
23. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood.
Wingen AM; Fabian-Bach C; Schaefer F; Mehls O
Lancet; 1997 Apr; 349(9059):1117-23. PubMed ID: 9113009
[TBL] [Abstract][Full Text] [Related]
24. Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.
Hall WD; Kusek JW; Kirk KA; Appel LJ; Schulman G; Agodoa LY; Glassock R; Grim C; Randall OS; Massry SG
Am J Kidney Dis; 1997 May; 29(5):720-8. PubMed ID: 9159306
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber MA; Franklin S; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T;
Ann Intern Med; 2006 Feb; 144(3):172-80. PubMed ID: 16461961
[TBL] [Abstract][Full Text] [Related]
26. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
27. Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
Mitsnefes M; Ho PL; McEnery PT
J Am Soc Nephrol; 2003 Oct; 14(10):2618-22. PubMed ID: 14514740
[TBL] [Abstract][Full Text] [Related]
28. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
Peterson JC; Adler S; Burkart JM; Greene T; Hebert LA; Hunsicker LG; King AJ; Klahr S; Massry SG; Seifter JL
Ann Intern Med; 1995 Nov; 123(10):754-62. PubMed ID: 7574193
[TBL] [Abstract][Full Text] [Related]
29. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group.
Levey AS; Greene T; Schluchter MD; Cleary PA; Teschan PE; Lorenz RA; Molitch ME; Mitch WE; Siebert C; Hall PM
J Am Soc Nephrol; 1993 Nov; 4(5):1159-71. PubMed ID: 8305642
[TBL] [Abstract][Full Text] [Related]
30. Cystatin C and blood pressure: results of 24 h ambulatory blood pressure monitoring.
Mena C; Robles NR; de Prado JM; Gallego FG; Cidoncha A
Eur J Intern Med; 2010 Jun; 21(3):185-90. PubMed ID: 20493420
[TBL] [Abstract][Full Text] [Related]
31. (99m)Tc-DTPA scintigraphy assesses the absence of glomerular filtration rate impairment of Aliskiren in high-risk hypertensive subjects. A 12-month follow-up study.
Mazza A; Montemurro D; Maffione AM; Vescovo G; Rampin L; Zuin M; Schiavon L; Camerotto A; Marzola MC; Fiorini F; Rubello D
Minerva Cardioangiol; 2014 Aug; 62(4):311-20. PubMed ID: 25012100
[TBL] [Abstract][Full Text] [Related]
32. [Prevalence of renal insufficiency in individuals with obesity].
Ležaić V; Zlatić N; Zogović J; Žarković B; Živković B; Žakula D; Živadinović N; Zuković M; Vasiljević N
Srp Arh Celok Lek; 2011; 139(11-12):772-9. PubMed ID: 22338474
[TBL] [Abstract][Full Text] [Related]
33. Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.
J Am Soc Nephrol; 1996 Dec; 7(12):2616-26. PubMed ID: 8989740
[TBL] [Abstract][Full Text] [Related]
34. "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis.
Toto RD; Mitchell HC; Smith RD; Lee HC; McIntire D; Pettinger WA
Kidney Int; 1995 Sep; 48(3):851-9. PubMed ID: 7474675
[TBL] [Abstract][Full Text] [Related]
35. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
[TBL] [Abstract][Full Text] [Related]
36. Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.
Chen Y; Lipkowitz MS; Salem RM; Fung MM; Bhatnagar V; Mahata M; Nievergelt CM; Rao F; Mahata SK; Schork NJ; Hicks PJ; Bowden DW; Freedman BI; Brophy VH; O'Connor DT;
Am J Nephrol; 2010; 32(1):23-30. PubMed ID: 20484896
[TBL] [Abstract][Full Text] [Related]
37. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
38. Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.
Elung-Jensen T; Heisterberg J; Sonne J; Strandgaard S; Kamper AL
Eur J Clin Pharmacol; 2005 Apr; 61(2):87-96. PubMed ID: 15761754
[TBL] [Abstract][Full Text] [Related]
39. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
40. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
